Trial Search Results

Dexmedetomidine Use in SZMN Blocks for Pediatric T&A Pain Control

The suprazygomatic maxillary nerve (SZMN) block is a well-established, safe and effective regional technique for pain management following cleft palate procedures. However, it has not been studied for patients undergoing tonsillectomy and adenoidectomy (T&A) procedures. The goal of this study is to determine whether the SZMN block can be utilized to improve pain control and decrease morbidity in pediatric patients undergoing T&A. An additional goal will be to determine whether the use of dexmedetomidine as a local anesthetic adjunct can prolong the analgesic effects of the SZMN block to cover the entire duration of pain experienced.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):

Intervention(s):

  • Procedure: SZMN block
  • Procedure: SZMN block with Dexmedetomidine

Phase:

N/A

Eligibility


Inclusion Criteria:

   - Ages 6 months - 18 years

   - Give consent/parental consent to participate in study

   - Patients undergoing tonsillectomy and adenoidectomy

Exclusion Criteria:

   - Participants who do not consent or have parental consent

   - Patients who require urgent/emergent intervention

   - Patients who undergo additional combined surgical procedures with separate incisions
   (in addition to the adenotonsillectomy)

   - Patients with known difficult airway, clinical hemodynamic instability, coagulopathy,
   chronic pain history, chronic pain medication use, and unrepaired congenital heart
   disease

   - Patients under age 6 months

Ages Eligible for Study

6 Months - 18 Years

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Ban CH Tsui, MD
(650) 200-9107
Not Recruiting